You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 416 SQ3370–001 is a multi-center open-label phase I dose-escalation study to test a novel intratumoral and systemic approach to treat advanced solid tumors

Alerts

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials in progress
416 SQ3370–001 is a multi-center open-label phase I dose-escalation study to test a novel intratumoral and systemic approach to treat advanced solid tumors
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address